Oxygenta [OXYGENTAPH] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Oxygenta Pharmaceutical Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oxygenta Pharmaceutical Ltd. wins in 6 metrics, Gujarat Themis Biosyn Ltd. wins in 12 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Oxygenta Pharmaceutical Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 444.32 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio -5.50 13.36 Gujarat Themis Biosyn Ltd.
Debt-to-Equity Ratio -1.99 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 19.02 -17.55 Oxygenta Pharmaceutical Ltd.
EV/EBITDA -15.15 52.76 Gujarat Themis Biosyn Ltd.
Profit Margin (TTM) -15.47% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) -14.55% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) N/A 40.16% N/A
Return on Equity 38.69% 19.64% Oxygenta Pharmaceutical Ltd.
Return on Assets (TTM) -11.61% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-87.89M $-251.22M Oxygenta Pharmaceutical Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -45.31% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 1.87 22.23 Oxygenta Pharmaceutical Ltd.
Enterprise Value $2.82B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 2.50 22.65 Oxygenta Pharmaceutical Ltd.
Gross Profit Margin (TTM) -4.06% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $31 $15 Oxygenta Pharmaceutical Ltd.
Earnings per Share (Diluted) $-4.72 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.52 -0.17 Gujarat Themis Biosyn Ltd.

Oxygenta Pharmaceutical Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

OXYGENTAPH
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta Pharmaceutical Ltd.1.71%-5.41%-12.37%-0.30%-20.06%-7.05%
Gujarat Themis Biosyn Ltd.2.45%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta Pharmaceutical Ltd.-45.31%60.31%375.14%380.79%624.83%225.39%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Oxygenta Pharmaceutical Ltd. vs Gujarat Themis Biosyn Ltd.

MetricOXYGENTAPHGUJTHEM
Market Information
Market Cap i₹2.00B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,43279,452
90 Day Avg. Volume i7,995106,446
Last Close₹50.70₹411.65
52 Week Range₹45.30 - ₹133.50₹225.05 - ₹479.00
% from 52W High-62.02%-14.06%
All-Time High₹133.50 (Jun 09, 2025)₹479.00 (Oct 27, 2025)
% from All-Time High-62.02%-14.06%
Growth Metrics
Quarterly Revenue Growth0.02%0.10%
Quarterly Earnings GrowthN/A-0.04%
Financial Health
Profit Margin (TTM) i-0.15%0.30%
Operating Margin (TTM) i-0.15%0.40%
Return on Equity (TTM) i0.39%0.20%
Debt to Equity (MRQ) i-1.9927.04
Cash & Liquidity
Book Value per Share (MRQ)₹-9.89₹24.29
Cash per Share (MRQ)₹0.34₹0.92
Operating Cash Flow (TTM) i₹-61,057,000₹970.68M
Levered Free Cash Flow (TTM) i₹-96,826,000₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend iN/A₹0.67

Valuation & Enterprise Metrics Analysis: Oxygenta Pharmaceutical Ltd. vs Gujarat Themis Biosyn Ltd.

MetricOXYGENTAPH (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i444.3273.73
Forward P/E iN/AN/A
PEG Ratio i19.02-17.55
Price to Sales (TTM) i1.8722.23
Price to Book (MRQ) i-5.5013.36
Market Capitalization
Market Capitalization i₹2.00B₹35.41B
Enterprise Value i₹2.82B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i2.5022.65
Enterprise to EBITDA i-15.1552.76
Risk & Other Metrics
Beta i0.52-0.17
Book Value per Share (MRQ) i₹-9.89₹24.29

Financial Statements Comparison: Oxygenta Pharmaceutical Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOXYGENTAPH (2025)GUJTHEM (2025)
Revenue/Sales i1.09B1.51B
Cost of Goods Sold i1.08B318.78M
COGS % of Revenue i98.5%21.1%
Gross Profit i16.68M1.19B
Gross Margin i1.5%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i-103.50M642.49M
Operating Margin i-9.5%42.6%
EBITDA i-84.49M713.04M
EBITDA Margin i-7.7%47.3%
Pre-Tax Income i-115.53M655.38M
Pre-Tax Income % of Revenue i-10.6%43.5%
Income Tax i-18.70M167.66M
Income Tax % of Revenue i-1.7%11.1%
Net Income (Profit) i-96.83M487.72M
Profit Margin i-8.9%32.3%

Balance Sheet & Liquidity Metrics

MetricOXYGENTAPH (2025)GUJTHEM (2025)
Cash & Equivalents i17,000116.94M
Total Current Assets i309.43M519.73M
Total Current Assets % of Revenue i28.3%34.5%
Total Current Liabilities i858.47M205.60M
Total Current Liabilities % of Revenue i78.5%13.6%
Long-Term Debt i215.22M296.36M
Long-Term Debt % of Revenue i19.7%19.7%
Total Shareholders Equity i-250.25M2.48B
Retained Earnings i-735.63M2.37B
Retained Earnings % of Revenue i-67.3%157.4%
Property, Plant & Equipment i14.36M411.30M

Cash Flow Statement Comparison

MetricOXYGENTAPH (2025)GUJTHEM (2025)
Operating Cash Flow i-61.06M970.68M
Operating Cash Flow % of Revenue i-5.6%64.4%
Capital Expenditures i-112.72M-1.16B
Free Cash Flow i-87.89M-251.22M
FCF Margin i-8.0%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i36.98M108.97M
Float Shares i4.87M29.52M
% Held by Insiders i81.94%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i18.06%26.84%

Dividend Analysis & Yield Comparison: Oxygenta Pharmaceutical Ltd. vs Gujarat Themis Biosyn Ltd.

MetricOXYGENTAPHGUJTHEM
Last 12-Month Dividend iN/A₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend iN/A₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends iN/A₹0.67
Ex-Dividend DateN/ASep 04, 2025